Jennifer Harmon

All I want is an end to Novel Psychoactive Substances (NPS). It’s a wish many of us in the forensic community share. NPS are the perennial “moving targets” of toxicology and drug chemistry, presenting an ongoing challenge to laboratory protocols and public safety. This week, we are diving into the messy world of synthetic benzodiazepines, specifically clonazolam and its […]

A new report from the RAND Corporation released in January 2026 provides a sobering look at the landscape of psychedelic use in the United States. As we move further into this “psychedelic renaissance,” it is critical to separate clinical interest from the forensic and toxicological realities we face in the field. DRE Classifications vs. Pharmacological Reality While